Related Experiment Video
Updated: Jul 19, 2026
07:22
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Is glycemic variability important to assessing antidiabetes therapies?
1University of Virginia Health System, Box 800137, Charlottesville, VA 22908, USA. boris@virginia.edu
Current Diabetes Reports
|November 2, 2006
Summary
This study introduces risk measures as a superior alternative to traditional statistics for analyzing glycemic variability from continuous glucose monitoring (CGM) data. These novel methods offer enhanced clinical insights into glucose fluctuations.
Area of Science:
- Endocrinology
- Biostatistics
- Medical Informatics
Background:
- Traditional statistical methods for glycemic variability lack clinical nuance.
- Existing metrics like standard deviation, M value, and glucose excursion analysis have limitations.
- Continuous glucose monitoring (CGM) data possess inherent temporal structures crucial for accurate interpretation.
Purpose of the Study:
- To propose and advocate for the use of risk measures for glycemic variability analysis.
- To highlight the clinical and numerical advantages of risk-based approaches.
- To emphasize the importance of temporal data structures in CGM analysis.
Main Methods:
- Exploration of alternative statistical approaches beyond traditional measures.
- Application of risk measures to quantify glycemic variability.
- Consideration of the temporal dynamics within CGM data streams.
Main Results:
- Risk measures demonstrate significant clinical and numerical advantages over conventional statistics.
- Incorporating temporal structures enhances the interpretation of CGM data.
- The proposed methods offer a more robust assessment of glycemic variability.
Conclusions:
- Risk measures represent a more advanced and clinically relevant method for assessing glycemic variability.
- Temporal analysis of CGM data is essential for comprehensive understanding.
- This approach can lead to improved patient management and outcomes.
Related Concept Videos
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:15Diabetes: Management and Pharmacotherapy
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
01:25Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Type 2 diabetes mellitus develops gradually and is often asymptomatic in early stages.Clinical ManifestationsWhen symptoms appear, they include fatigue, blurred vision, pruritus, delayed wound healing, and recurrent infections, particularly candidal infections. Peripheral neuropathy may present as numbness or tingling in the extremities. Classic hyperglycemia symptoms—polyuria, polydipsia, and polyphagia—are less common. Most patients are overweight and frequently have associated hypertension...
01:11Variability: Analysis
Measures of variability are statistical metrics that reveal the dispersion pattern within a dataset. They are pivotal in biostatistics, providing insights into the heterogeneity within health and biological data. Variability signifies the degree to which data points diverge from one another, helping researchers understand the potential range of values and associated uncertainty within the data.
The range is a simple measure of variability, indicating the difference between the highest and...
The range is a simple measure of variability, indicating the difference between the highest and...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...